天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook--->CAS DataBase List--->2606990-92-3

2606990-92-3

2606990-92-3 Structure

2606990-92-3 Structure
IdentificationBack Directory
[Name]

WM382
[CAS]

2606990-92-3
[Synonyms]

WM382
[Molecular Formula]

C29H36N4O4
[MOL File]

2606990-92-3.mol
[Molecular Weight]

504.62
Chemical PropertiesBack Directory
[density ]

1.30±0.1 g/cm3(Predicted)
[form ]

Solid
[pka]

13.84±0.40(Predicted)
[color ]

White to off-white
Hazard InformationBack Directory
[Description]

WM-382 is a PMX inhibitor with antimalarial activity. Oral administration of WM382 cured mice of P. berghei and prevented blood infection from the liver. In addition, WM382 was efficacious against P. falciparum asexual infection in humanized mice and prevented transmission to mosquitoes
[Uses]

WM382 is an orally active and potent dual plasmepsin IX/X (PMIX/X) inhibitor with IC50 values of 1.4 nM and 0.03 nM, respectively. WM382 has robust in vivo efficacy at multiple stages of the malaria parasite life cycle and an excellent resistance profile[1][2][3].
[in vivo]

WM382 (20 mg/kg twice daily or 1-30 mg/kg once daily; p.o.; for 4 d) can clear mouse models of P. berghei and P. falciparum parasites. WM382 is also efficacious against P. falciparum asexual infection in humanized mice and prevents transmission to mosquitoes[3].

Animal Model:Mice infected with P. berghei[3]
Dosage:20 mg/kg
Administration:Oral gavage; twice daily for 4 days; monitored for 30 days
Result:Cured mice of P. berghei and prevents blood infection from the liver.
Animal Model:Humanized nonobese diabetic-severe combined immunodeficiency (NOD-scid) IL2Rgnull mouse model (NSG)[3]
Dosage:1, 3, 10, 30 mg/kg
Administration:Oral gavage; once daily for 4 days; monitored for 7 days
Result:Cleared of parasitemia by day 6 at 30 mg/kg or day 7 at 3 and 10 ma/kg.
[IC 50]

Plasmodium
[References]

[1] Manuel de LR, et al. The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria. ACS Med Chem Lett. 2022 Oct 12.
[2] Hodder AN, et al. Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax. Structure. 2022 Jul 7;30(7):947-961.e6. DOI:10.1016/j.str.2022.03.018
[3] Favuzza P, et al. Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle. Cell Host Microbe. 2020 Apr 8;27(4):642-658.e12. DOI:10.1016/j.chom.2020.02.005
2606990-92-3 suppliers list
Company Name: Chengdu PEIP Pharmaceutical Technology Co., LTD.  
Tel: 028-61715638 18011352545
Website: www.approvedhomemanagement.com/ShowSupplierProductsList554034/0.htm
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Tel: 0513-66337626 18051384581
Website: https://www.chemhifuture.com/
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:2606990-92-3 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.